A sum of its parts: A systematic review evaluating biopsychosocial and behavioral determinants of perinatal depression

Depression is one of the most common yet underdiagnosed perinatal complications and our understanding of the pathophysiology remains limited. Though perinatal depression is considered to have a multifactorial etiology, integrative approaches to investigation are minimal. This review takes an integrative approach to systematically evaluate determinants and potential interactions among determinants of perinatal depression across four domains (i.e., biological, behavioral, environmental, social) and appraise the quality of methods applied. Four databases (i.e., PubMed, CINAHL, APA PsycInfo, and Web of Science) were systematically searched to identify studies examining determinants of perinatal depression in adult perinatal persons ([≥] 18 years). Articles were excluded if the outcomes were not focused on perinatal persons and depression or depression symptoms, the evaluation of depression was specific to a discrete facet of the perinatal period with probable psychological consequences (e.g., abortion, fetal/infant loss, adoption), or was considered grey literature. The Critical Appraisal Skills Programme and AXIS tools were used to guide and standardize quality appraisal assessments and determine the level of risk of bias. Of the 454 articles identified, 25 articles were included for final review. A total of 14 categories of determinants were investigated: biological (5), behavioral (4), social and environmental (5). Though only 28% of studies simultaneously considered determinants under more than one domain, a pattern of interactions with the tryptophan pathway emerged when determinants across domains were aggregated. Concerns for risk of bias were noted or were unclear for three types of bias: 13 (52%) selection bias, 3 (12%) recall bias, and 24 (96%) measurement bias. Future research is needed to explore interactions among determinants and the tryptophan pathway; to strengthen the methods applied to this area of inquiry; and to generate evidence for best practices in reporting, selecting, and applying methods for measuring determinants and perinatal depression.

[1]  Lorie A. Kloda,et al.  Individual participant data meta-analysis to compare EPDS accuracy to detect major depression with and without the self-harm item , 2023, Scientific Reports.

[2]  N. Vale,et al.  Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways , 2022, International journal of molecular sciences.

[3]  S. Sasaki,et al.  Tryptophan intake is related to a lower prevalence of depressive symptoms during pregnancy in Japan: baseline data from the Kyushu Okinawa Maternal and Child Health Study , 2022, European Journal of Nutrition.

[4]  Michelle Osterman J. K..  Changes in primary and repeat cesarean delivery: United States 2016-2021 , 2022 .

[5]  Yutang Wang,et al.  Tryptophan-rich diet ameliorates chronic unpredictable mild stress induced depression- and anxiety-like behavior in mice: The potential involvement of gut-brain axis. , 2022, Food research international.

[6]  Xin-qiang Wang,et al.  Meta-analysis of association between TPH2 single nucleotide poiymorphism and depression , 2021, Neuroscience & Biobehavioral Reviews.

[7]  Xiangdong Chen,et al.  Risk factors of perinatal depression in women: a systematic review and meta-analysis , 2022, BMC Psychiatry.

[8]  T. Postolache,et al.  Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy , 2022, Translational Psychiatry.

[9]  Rebecca C. Knickmeyer,et al.  Metabolite trajectories across the perinatal period and mental health: A preliminary study of tryptophan-related metabolites, bile acids and microbial composition , 2021, Behavioural Brain Research.

[10]  G. Úrrutia,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. , 2021, Revista espanola de cardiologia.

[11]  Ashley J Blount,et al.  Biopsychosocial Factors during the Perinatal Period: Risks, Preventative Factors, and Implications for Healthcare Professionals , 2021, International journal of environmental research and public health.

[12]  Shu Lin,et al.  Neuropeptide Y and Metabolism Syndrome: An Update on Perspectives of Clinical Therapeutic Intervention Strategies , 2021, Frontiers in Cell and Developmental Biology.

[13]  Jacquelyn C. Campbell,et al.  Pregnancy-Associated Deaths from Homicide, Suicide, and Drug Overdose: Review of Research and the Intersection with Intimate Partner Violence , 2020, Journal of women's health.

[14]  B. Bharadwaj,et al.  Cross-sectional association between vitamin B12 status and probable postpartum depression in Indian women , 2020, BMC Pregnancy and Childbirth.

[15]  F. Valtorta,et al.  Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample , 2020, Brain, Behavior, and Immunity.

[16]  Leslie L. Harrison,et al.  Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression — United States, 2018 , 2020, MMWR. Morbidity and mortality weekly report.

[17]  J. Payne,et al.  Perinatal depression: A review , 2020, Cleveland Clinic Journal of Medicine.

[18]  B. F. Hutchens,et al.  Risk Factors for Postpartum Depression: An Umbrella Review. , 2020, Journal of midwifery & women's health.

[19]  C. Lim,et al.  Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression , 2019, Brain, Behavior, and Immunity.

[20]  Marguerite Schneider,et al.  Perinatal depressive symptoms among low-income South African women at risk of depression: trajectories and predictors , 2019, BMC Pregnancy and Childbirth.

[21]  C. Mu,et al.  Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota–brain axis , 2019, Journal of neurochemistry.

[22]  J. Pawluski,et al.  Serotonin and motherhood: From molecules to mood , 2019, Frontiers in Neuroendocrinology.

[23]  J. Savitz.  The Kynurenine Pathway: A Finger in Every Pie , 2019, Molecular Psychiatry.

[24]  American Congress of Obstetricians and Gynecologists (ACOG) , 2018, The Grants Register 2019.

[25]  L. Christian,et al.  Pathways linking childhood abuse history and current socioeconomic status to inflammation during pregnancy , 2018, Brain, Behavior, and Immunity.

[26]  Jason E. Waller,et al.  Division , 2018, Bad Arguments.

[27]  Mei-Chi Hsu,et al.  Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation. , 2018, Journal of affective disorders.

[28]  S. Meltzer-Brody,et al.  Predictors of Postpartum Depression: A Comprehensive Review of the Last Decade of Evidence. , 2018, Clinical obstetrics and gynecology.

[29]  J. Pérez-Tejada,et al.  Biological Sex Differences in Depression: A Systematic Review , 2018, Biological research for nursing.

[30]  D. Fuchs,et al.  Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy , 2018, Biological research for nursing.

[31]  J. Chang,et al.  Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[33]  R. Dantzer,et al.  Sleep disturbance and kynurenine metabolism in depression. , 2017, Journal of psychosomatic research.

[34]  A. Shorten.  Midwifery and women's health , 2017, Evidence Based Journals.

[35]  Ann Borders,et al.  Close relationship qualities and maternal peripheral inflammation during pregnancy , 2017, Psychoneuroendocrinology.

[36]  Rachel S Dean,et al.  Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) , 2016, BMJ Open.

[37]  Ming Li,et al.  MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders , 2016, Molecular Neurobiology.

[38]  D. Mazmanian,et al.  Breastfeeding and Postpartum Depression: An Overview and Methodological Recommendations for Future Research , 2016, Depression research and treatment.

[39]  Carmine M. Pariante,et al.  Identifying the women at risk of antenatal anxiety and depression: A systematic review , 2016, Journal of affective disorders.

[40]  P. Riederer,et al.  Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression , 2016, Journal of Neural Transmission.

[41]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[42]  P. Stover,et al.  Vitamin B-12 and Perinatal Health. , 2015, Advances in nutrition.

[43]  C. Dunkel Schetter,et al.  Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. , 2015, Annual review of clinical psychology.

[44]  H. Corrêa,et al.  Postpartum depression: A systematic review of the genetics involved. , 2015, World journal of psychiatry.

[45]  A. Aleman,et al.  Influence of COMT val158met Genotype on the Depressed Brain during Emotional Processing and Working Memory , 2013, PloS one.

[46]  M. Freeman,et al.  Antidepressant use in pregnancy: a critical review focused on risks and controversies , 2013, Acta psychiatrica Scandinavica.

[47]  S. Matthey,et al.  Edinburgh Postnatal Depression Scale , 2011 .

[48]  B. Elvevåg,et al.  Genes, cognition and brain through a COMT lens , 2009, Neuroscience.

[49]  H. Ko,et al.  Population-specific functional variant of the TPH2 gene 2755C>A polymorphism contributes risk association to major depression and anxiety in Chinese peripartum women , 2009, Archives of Women's Mental Health.

[50]  Bobbie Posmontier.  Functional status outcomes in mothers with and without postpartum depression. , 2008, Journal of midwifery & women's health.

[51]  C. Markus.  Dietary Amino Acids and Brain Serotonin Function; Implications for Stress-Related Affective Changes , 2008, NeuroMolecular Medicine.

[52]  M. Guha.  APA Dictionary of Psychology , 2007 .

[53]  B. Beck,et al.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[54]  J. Launay,et al.  Decreased brain tryptophan availability as a partial determinant of post-partum blues , 2006, Psychoneuroendocrinology.

[55]  Pablo A. Mora,et al.  Racial and Ethnic Differences in Factors Associated With Early Postpartum Depressive Symptoms , 2005, Obstetrics and gynecology.

[56]  Young-Joo Park,et al.  [The predictors of postpartum depression]. , 2004, Taehan Kanho Hakhoe chi.

[57]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[58]  H. Hendrie,et al.  Plasma tryptophan and five other amino acids in depressed and normal subjects. , 1981, Archives of general psychiatry.

[59]  S. Handley,et al.  Tryptophan, Cortisol and Puerperal Mood , 1980, British Journal of Psychiatry.

[60]  P. McGuffin,et al.  A Clinical Scale for the Self-assessment of Irritability , 1978, British Journal of Psychiatry.

[61]  A. Bedford,et al.  A new personal disturbance scale (DSSI/sAD). , 1976, The British journal of social and clinical psychology.

[62]  Margaret R. Emerson,et al.  Postpartum Depression Screening for New Mothers at Well Child Visits , 2018, MCN. The American journal of maternal child nursing.

[63]  S. Kushner,et al.  Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression. , 2016, Journal of affective disorders.

[64]  A. Gulledge,et al.  Nutritional Impact on Cognitive Development , 2014 .

[65]  A. Neumeister.  Tryptophan depletion, serotonin, and depression: where do we stand? , 2003, Psychopharmacology bulletin.

[66]  J. Geddes,et al.  Depressive disorders. , 2003, Clinical evidence.